The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff
A Pilot Study Examining Participants Psychosocial Health, Physical Activity and Staff Experiences: Is Adapted Home-based Phase 3 Cardiac Rehabilitation Feasible and Beneficial?
1 other identifier
observational
30
0 countries
N/A
Brief Summary
What are the experiences of staff and participants in phase 3 cardiac rehabilitation during the Covid-19 pandemic, and what impacts have adapted delivery had on participants' physical activity levels, mental health and well-being? Cardiac rehabilitation (CR) is a vital service for individuals diagnosed and treated for cardiovascular disease (e.g., heart attack, angina, valve disease). The service helps to improve recovery rates through supporting patients with beneficial lifestyle changes (e.g., physical activity, healthy eating), and coping with emotional distress following a traumatic cardiac event. The environment in which CR is being delivered has changed in response to the Covid-19 pandemic, including remote working practices, and in some instances postponing of rehabilitation. Despite the public health rationale for such measures, it is essential to consider the impact of adapted services on patient's mental health and physical activity participation, and to consider staff experiences in using remote working regimes. The current study aims to recruit staff and patients from phase 3 cardiac rehabilitation across Hampshire Hospitals Foundation Trust to explore their experiences of adapted services through a mixed methods study design. Staff and patients will be interviewed over the phone to explore experiences and impacts of Covid-19 with their rich in-depth viewpoints and stories. In addition, during an 8 week period of rehabilitation, patients will be asked to report and record their physical activity levels with diaries and accelerometers (a wrist worn device measuring movement), record their resting blood pressure and heart rate, and complete questionnaires to assess changes in mental health. This study could help to understand the impact of the pandemic on cardiac patients recovery and on staff's experiences implementing programme changes to assist in preparing for the future of CR post COVID 19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2021
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedFirst Posted
Study publicly available on registry
February 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedFebruary 5, 2021
January 1, 2021
1.3 years
January 29, 2021
February 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Psychosocial health and wellbeing
Semi structured interviews
During qualitative interviews (post week 5).
Secondary Outcomes (8)
Acceptability to Participants
During qualitative interviews after the intervention has ended (post week 5).
Feasible to Participants
During qualitative interviews after the intervention has ended (post week 5).
Physical activity
Week 1, 4 and 8 of rehabilitation
Loneliness
Week 1, 4 and 8 of rehabilitation
Heart rate
Week 1, 4 and 8 of rehabilitation
- +3 more secondary outcomes
Interventions
Phase 3 CR is a comprehensive outpatient programme, considered the core rehabilitation phase, in which participants receive structured exercise, health education, risk factor modification and psychological support. Upon discharge from clinically supervised phase 3 CR participants are generally signposted to long-term community-based exercise classes (phase 4). The current study will take place within a core phase 3 CR programme in the UK.
Eligibility Criteria
Service user participants are individuals treated for acute coronary syndromes (e.g., NSTEMI, STEMI), heart failure, valve disease, and ICD's. Staff participants will be recruited from members of a multidisciplinary team including; CR professionals including CR specialist nurses, physiotherapists and exercise practitioners.
You may qualify if:
- Aged 18 years or over
- Staff and participants participating in Phase 3 CR
- Able to give informed consent
- Willing and able to undertake the interview, diary, questionnaire and accelerometer processes
You may not qualify if:
- Aged \<18 years
- Not participating in Phase 3 CR
- Any individuals who are unable to represent their own interests or are particularly susceptible to coercion (vulnerable individuals), and are therefore unable to give informed consent
- If individuals have difficulties in adequately understanding written or verbal information in English, as the study doesn't have funding for a translator or interpreter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ant Shepherdlead
- Hampshire Hospitals NHS Foundation Trustcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Lecturer in Physical Activity, Exercise and Health
Study Record Dates
First Submitted
January 29, 2021
First Posted
February 5, 2021
Study Start
February 1, 2021
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
February 5, 2021
Record last verified: 2021-01